Osteoporosis

Drug significantly reduces vertebral fracture risk in postmenopausal women

Published in Women's Health Weekly, February 19th, 2004

Results of a major new study show that a novel treatment for osteoporosis, Protelos (S12911, strontium ranelate), significantly reduces the risk of new vertebral fractures in osteoporotic postmenopausal women.

The study data on Protelos, manufactured by Servier Laboratories Ltd., were published in the January 29, 2004, issue of the New England Journal of Medicine (N Engl J Med, 2004;350:459-468). The lead author of the paper is Pierre J. Meunier, MD, Department of Rheumatology and Bone Diseases, Edouard Herriot Hospital, Lyons, France.

The Spinal Osteoporosis Therapeutic Intervention (SOTI) study, a large international randomized,...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Women's Health Weekly

Source: Women's Health Weekly (2004-02-19)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry